BIEGLER GmbH was founded in Mauerbach (near Vienna) in 1973.
Our mission is to provide innovative, high-quality solutions for the medical profession.
In our 40 years of experience, this mission has remained unchanged.

2019

Continuous progress in international market approach and product development

2015

Expansion of machinery and modernization

2013

Expansion of the clean room, development of OEM services

2012

Expansion of OEM production

2011

Expansion of the warming product range, intensified development work for BAXTER, exterior refurbishment

2010

Corporate video in the form of an electronic business card.
Electrical stimulation redesigned.
Strengthening of Biegler`s market presence in Austria

2009

Implementation of a new ERP program, corporate design improved, blood warmer range redesigned

2007

Expansion of OEM products with EMCOOLS cooling pad system for emergency medicine, project planning for new building

2006

FDA approval granted for P-STIM and start of US market cultivation, launch of new application system for fibrin sealant

2005

OEM campaign, new OEM partners, FDA approval process for P-STIM

2004

OEM campaign, new OEM partners

2003

Production streamlining, expansion of the export markets for new products.

2002

Additional purchase of more land adjoining the existing premises as an expansion option.
Development of a new therapy device for the inspiratory muscles in chronic obstructive pulmonary diseases.
Transition of point stimulation to production.

2001

Acquisition of additional machining centers in the mechanical, machining production division, entry into SMD technology as part of electronic manufacturing.

2000

Implementation of a class 100,000 clean room production area for sterile disposable products (catheters, application systems for fibrin sealant). Expansion of the plastic injection molding technology division, in terms of both space and machinery.

1999

Inclusion of another OEM product (respiratory nebulizer) for Siemens in Solna, Sweden.
Product expansion in infusion technology for surgical medicine and intensive care.
Start of development work for point stimulation.

1995

Opening of a new research and development division, plus additional storage and conference rooms in another new production and office building.

1991

Purchase of land to permit the expansion of the mechanical production plant.

1985

Plastics division premises expanded and new production facility constructed.

1982

Production and assembly premises developed.

1980

On the basis of the structural improvement law (promotion of enterprises), Biegler was transformed into a GesmbH [limited liability company].

1979

Collaboration with Immuno (now the US Baxter Group) with respect to fibrin sealant resulted in an expansion of our product range.

1973

Foundation

Biegler - Video